Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Experts are expecting strong results driven by the strong demand of Lilly's blockbuster medications, particularly recent launches. However, there are also concerns about potential challenges from